{{Rsnum
|rsid=2556378
|Gene=BCL11A
|Chromosome=2
|position=60535367
|Orientation=plus
|GMAF=0.2213
|Gene_s=BCL11A
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(G;G)
|geno2=(G;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(G;G)
| geno2=(G;T)
| geno3=(T;T)
| CEU | 69.0 | 26.5 | 4.4
| HCB | 54.4 | 38.2 | 7.4
| JPT | 61.6 | 35.7 | 2.7
| YRI | 52.7 | 41.1 | 6.2
| ASW | 70.2 | 22.8 | 7.0
| CHB | 54.4 | 38.2 | 7.4
| CHD | 61.9 | 32.4 | 5.7
| GIH | 69.3 | 27.7 | 3.0
| LWK | 57.8 | 39.4 | 2.8
| MEX | 43.1 | 48.3 | 8.6
| MKK | 54.8 | 40.0 | 5.2
| TSI | 63.4 | 34.7 | 2.0
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=22012869
|Trait=None
|Title=Genome-wide association study in German patients with attention deficit/hyperactivity disorder.
|RiskAllele=T
|Pval=0.000007
|OR=None
|ORtxt=None
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA}}
{{on chip | Illumina Human 1M}}